SWK
56
-2
DHI
31
-2
ISRG
66
-3
BMY
64
-5
IRM
44
3
NOC
45
-2
FRT
53
3
EL
46
-2
COP
45
-2
ES
47
2
DHR
63
-3
WHR
51
-2
WMB
48
-3
MU
68
2
HON
60
-3
SEE
53
-3
FTI
69
5
NRG
55
3
GPC
53
-4
IP
28
-6
SWK
56
-2
DHI
31
-2
ISRG
66
-3
BMY
64
-5
IRM
44
3
NOC
45
-2
FRT
53
3
EL
46
-2
COP
45
-2
ES
47
2
DHR
63
-3
WHR
51
-2
WMB
48
-3
MU
68
2
HON
60
-3
SEE
53
-3
FTI
69
5
NRG
55
3
GPC
53
-4
IP
28
-6
Financhill
Back

Arianne Phosphate, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
26

DRRSF
Arianne Phosphate, Inc.

Last Price:
$0.15
Seasonality Move:
-1.25%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.98
Seasonality Move:
7.7%
Sell
26
Arianne Phosphate, Inc. (DRRSF) is a Sell

Is Arianne Phosphate, Inc. a Buy, Sell or Hold?

  • The current Arianne Phosphate, Inc. [DRRSF] share price is $0.15. The Score for DRRSF is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • DRRSF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

DRRSF Stock Price Chart

What is Arianne Phosphate, Inc.'s stock price today?

  • The Arianne Phosphate, Inc. share price today is $0.15
    The current trend is relatively stagnant and DRRSF is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $86.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

DRRSF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 52.52 Buy
Chaikin Money Flow: -14906 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.14 - 0.16) Buy
Bollinger Bands (100): (0.11 - 0.15) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 72.81 Buy
Chaikin Money Flow: -897315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.72 - 73.96) Buy
Bollinger Bands (100): (43.27 - 64.19) Buy

DRRSF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.15 Sell
20-day SMA: 0.15 Buy
50-day SMA: 0.15 Buy
200-day SMA: 0.12 Buy
8-day EMA: 0.15 Buy
20-day EMA: 0.15 Buy
50-day EMA: 0.14 Buy
200-day EMA: 0.09 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.38 Buy
20-day SMA: 67.89 Buy
50-day SMA: 62.54 Buy
200-day SMA: 44.51 Buy
8-day EMA: 75.59 Buy
20-day EMA: 69.41 Buy
50-day EMA: 62.91 Buy
200-day EMA: 49.79 Buy

Arianne Phosphate, Inc. Earnings Growth & DRRSF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.

Arianne Phosphate, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):